Development code · Small Molecule
CPL'36
CPL'36 is a development code for Alofropodect, developed by Celon Pharma S.A..
- Status
- Phase 2 for Schizophrenia
- Mechanism
- PDE10A Inhibitor
- Developer
- Celon Pharma S.A.
Programs
- Alofropodect for SchizophreniaPhase 2Active
- Alofropodect for Levodopa-induced dyskinesia in Parkinson's diseasePhase 2Active
Also known as
- CPL500036
- CPL-500036
- CPL 500036
- CPL36
- alofropodect
- 1829530-11-1
- 5,8-dimethyl-2-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)-[1,2,4]triazolo[1,5-a]pyrazine